Cargando…
GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells
Lack of targetable antigens is a key limitation for developing successful T cell-based immunotherapies. Members of the unfolded protein response (UPR) represent ideal immunotherapy targets because the UPR regulates the ability of cancer cells to resist cell death, sustain proliferation, and metastas...
Autores principales: | Ibanez, Jorge, Hebbar, Nikhil, Thanekar, Unmesha, Yi, Zhongzhen, Houke, Haley, Ward, Meghan, Nevitt, Chris, Tian, Liqing, Mack, Stephen C., Sheppard, Heather, Chiang, Jason, Velasquez, M. Paulina, Krenciute, Giedre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694756/ https://www.ncbi.nlm.nih.gov/pubmed/37992682 http://dx.doi.org/10.1016/j.xcrm.2023.101297 |
Ejemplares similares
-
DIPG-34. IMMUNE SYNAPSE OPTIMIZED GRP78-SPECIFIC CAR T CELLS ELICIT AN IMPROVED ANTITUMOR RESPONSE AGAINST DIPGS
por: Ibanez, Jorge, et al.
Publicado: (2023) -
CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells
por: Hebbar, Nikhil, et al.
Publicado: (2022) -
GRP78 Is a Targetable Receptor on Cancer and Stromal Cells
por: Araujo, Nathalia, et al.
Publicado: (2018) -
GRP78 in lung cancer
por: Xia, Shengkai, et al.
Publicado: (2021) -
Mitochondrial metabolic regulation by GRP78
por: Prasad, Manoj, et al.
Publicado: (2017)